Welcome to our dedicated page for Curaleaf Hldgs SEC filings (Ticker: CURLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Curaleaf Holdings, Inc. files foreign issuer reports that document its cannabis operations, financial statements, governance actions, and capital-structure matters. Recent Form 6-K filings include interim consolidated financial statements, management discussion and analysis, CEO and CFO certifications, press releases, and documents incorporated by reference into a Form F-10 registration statement.
The filing record covers auditor changes, annual and special meeting matters, director elections, auditor appointment, equity incentive plan items, multiple voting share provisions, subordinate voting shares, normal course issuer bid activity, automatic securities disposition plans, and completed acquisition disclosures for Four 20 Pharma.
Curaleaf Holdings, Inc. filed a Form 6-K furnishing its unaudited condensed interim consolidated financial statements and Management’s Discussion and Analysis for the three and nine months ended September 30, 2025, together with comparative information as of December 31, 2024.
The submission includes CEO and CFO certifications of interim filings and a press release dated November 5, 2025. Exhibit 99.1 is incorporated by reference into Curaleaf’s Registration Statement on Form F-10 (File No. 333-269109).